BMY

58.8000.79%
CM

Cristian Massacesi

Executive VP, Chief Medical Officer & Head of Development

Dr. Cristian Massacesi, M.D. is Executive VP, Chief Medical Officer & Head of Development of Bristol-Myers Squibb Company from August 1, 2025. Mr. Massacesi was Chief Medical Officer and Oncology Chief Development Officer - Oncology R&D at AstraZeneca PLC since August 2021 and was Senior Vice President, Head of Late Stage Development Oncology since September 2019 until August 2021. Over the last several years, he has lectured extensively on topics including immunotherapy clinical trials, breast cancer and clinical development of PI3K inhibitors. He has published on a wide range of cancer topics, authoring nearly 50 peer-reviewed papers and more than 100 conference abstracts. He has also generated several patents for cancer treatment combinations and regimens. A medical doctor by training, he began his career in medical oncology after serving as a physician in the Italian Army. He earned his medical degree from Marche Polytechnic University and received medical oncology training at the Royal Marsden Hospital, Kaplan Comprehensive Cancer Center and the European Institute of Oncology.

Positions